Developmental Funds

$177,233P30FY2009CANIH

Beckman Research Institute/City Of Hope, Duarte CA

Investigators

Linked publications & trials

Paper 39763987 Paper 39763913 Paper 39732733 Paper 39711954 Paper 39695058 Paper 39682101 Paper 39682092 Paper 39677768 Paper 39633366 Paper 39606335 Paper 39595636 Paper 39582064 Paper 39561207 Paper 39545637 Paper 39538011 Paper 39487323 Paper 39470734 Paper 39440943 Paper 39409988 Paper 39389979 Paper 39371135 Paper 39229097 Paper 39198030 Paper 39171140 Paper 39159874 Paper 39157928 Paper 39149360 Paper 39148906 Paper 39147891 Paper 39145457 Paper 39143574 Paper 39138107 Paper 39134907 Paper 39128904 Paper 39124569 Paper 39123463 Paper 39088329 Paper 39051632 Paper 39051454 Paper 39017946 Paper 38993482 Paper 38977974 Paper 38960886 Paper 38942763 Paper 38925328 Paper 38917002 Paper 38910325 Paper 38905124 Paper 38898200 Paper 38867077 Paper 38852379 Paper 38838232 Paper 38836758 Paper 38826403 Paper 38811525 Paper 38800943 Paper 38797530 Paper 38767375 Paper 38748755 Paper 38742734 Paper 38715647 Paper 38701936 Paper 38648576 Paper 38645262 Paper 38604313 Paper 38596681 Paper 38530242 Paper 38527998 Paper 38497709 Paper 38484137 Paper 38479932 Paper 38464266 Paper 38454126 Paper 38449858 Paper 38448681 Paper 38433896 Paper 38426277 Paper 38413714 Paper 38405814 Paper 38401418 Paper 38394668 Paper 38394203 Paper 38386696 Paper 38384444 Paper 38382358 Paper 38354149 Paper 38339304 Paper 38317590 Paper 38316881 Paper 38315779 Paper 38307941 Paper 38282415 Paper 38280052 Paper 38262235 Paper 38251974 Paper 38247509 Paper 38233463 Paper 38222540 Paper 38211590 Paper 38206366

Abstract

In the past funding period, the City of Hope Comprehensive Cancer Center distributed awards for 12 pilot projects in the amount of $485,000 to encourage collaborative projects or high-risk research of Center members. Grants exceeding $2,800,000 resulted from several of these collaborations, including one project grant of our new lymphoma SPORE and several R01s. The Center also provided $100,000 over 2 years in support of the developing core, Clinical Immunobiology Correlative Studies Laboratory, which is a new shared resource in this renewal application. During the next funding period, the COHCCC has undertaken an ambitious goal: to accelerate its translational research activities through recruitment and program and infrastructure development so that we increase[unreadable]with speed, safety, and effectiveness[unreadable]the density of innovative laboratory discoveries reaching in-house clinical trials. We propose to use our developmental funds, a requested total of $250,000 yearly, to support programmatic growth as follows: [unreadable] $100,000 yearly for 2 to 3 projects focused in the three clinical programs[unreadable]breast, prostate, and thoracic malignancies[unreadable]that we have targeted for evolution into Center research programs on the occasion of the next CCSG renewal. [unreadable] Each project to pair a clinical and laboratory researcher in the disease area We will advance our infrastructure by developing three new shared resources: [unreadable] High Throughput Screening to identify small molecular modulators of cancer therapeutics targets identified by Center investigators ($50,000/year for 3 years) [unreadable] Synthetic and Biopolvmer Chemistry to pursue small-molecule structure/activity relationships ($50,000/year for 3 years) [unreadable] Survey Research to assist our population sciences investigators in gathering data from dispersed research subjects in an efficient process that is compliant with institutional and governmental regulations ($50,000/year for 3 years)

View original record on NIH RePORTER →